GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lee's Pharmaceutical Holdings Ltd (OTCPK:LPCUF) » Definitions » 6-1 Month Momentum %

LPCUF (Lee's Pharmaceutical Holdings) 6-1 Month Momentum % : -5.90% (As of Mar. 02, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Lee's Pharmaceutical Holdings 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2025-03-02), Lee's Pharmaceutical Holdings's 6-1 Month Momentum % is -5.90%.

The industry rank for Lee's Pharmaceutical Holdings's 6-1 Month Momentum % or its related term are showing as below:

LPCUF's 6-1 Month Momentum % is ranked better than
51.69% of 1066 companies
in the Drug Manufacturers industry
Industry Median: -3.15 vs LPCUF: -5.90

Competitive Comparison of Lee's Pharmaceutical Holdings's 6-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Lee's Pharmaceutical Holdings's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lee's Pharmaceutical Holdings's 6-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lee's Pharmaceutical Holdings's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Lee's Pharmaceutical Holdings's 6-1 Month Momentum % falls into.



Lee's Pharmaceutical Holdings  (OTCPK:LPCUF) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lee's Pharmaceutical Holdings  (OTCPK:LPCUF) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Lee's Pharmaceutical Holdings 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Lee's Pharmaceutical Holdings's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lee's Pharmaceutical Holdings Business Description

Traded in Other Exchanges
Address
Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG
Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue, and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.

Lee's Pharmaceutical Holdings Headlines

No Headlines